Psoriasis is a chronic immune-mediated disease of the skin, with wide dermatological manifestations, most commonly involving erythematous, scaly plaques on the extensor surfaces of the joints, whereas psoriatic arthritis is also a common coexisting ...
A Great Leap forward in Therapeutic Development Discoveries of molecular mechanisms of different diseases provide unprecedented opportunities to develop novel medicines. However, the research and development of a brand-new drug is time-consuming and...
The Establishment of Consensus Statements on Management of Systemic Lupus Erythematosus for Asia-Pacific Region Systemic lupus erythematosus (SLE) is a multi-systemic autoimmune disease characterised by periods of exacerbation and remission, with or...
Rheumatoid arthritis (RA) is an autoimmune disorder caused by synovial inflammation of the joints, resulting in severe swelling and pain. Although the disease is incurable, previous studies have suggested that tea consumption may reduce the risk of ...
Adult patients with active ankylosing spondylitis (AS) treated with intravenously (IV) administered an anti-tumor necrosis factor (anti-TNF) monoclonal antibody, golimumab (GOL), demonstrated improvements in sleep problems, total back pain (TBP) and...
Biologic or targeted synthetic disease modifying anti-rheumatic drugs (DMARDs) are well-known for increasing the risk of serious infections (SI). Few studies conducted in real-world setting directly compared the incidence rate (IR) of serious bacter...
Real Life 12 Year Retention Rate of Subcutaneous Anti-TNF in Spondyloarthritis. Results from a Multicenter Cohort of 1170 Patients By Dr. Andus Ng Spondyloarthritis (SpA) patients starting golimumab (GOL) have the best drug retention compared to tho...
The Complexity of NPSLE The definition of neuropsychiatric symptoms in SLE (NPSLE) is a tough challenge owing to the broad spectrum of neuropsychiatric (NP) symptoms that it encompasses, most of which are non-specific. In 1999, the American College ...
Treatment of Systemic Lupus Erythematosus: More than Disease Control Systemic lupus erythematous (SLE) is a complex, multisystem autoimmune disease with a heterogeneous range of clinical and immunological manifestations 1 . The development of diseas...
Psoriatic Arthritis (PsA) has been identified as a potentially destructive, disabling arthritis and affects women and men equally, with a prevalence of approximately 1 to 2 per 1000 in the general population 8 . Over the past few years, there has be...
The Unmet Needs in RA Treatments Thanks to the development in therapeutics for RA in recent decades, better clinical remission can be achieved. However, the patient-reported pain, fatigue and disease activity level were not coincidental with the sev...
Risk Prediction and Preconception Counselling on Adverse Pregnancy Outcomes in Systemic Lupus Erythematosus Pregnancy is challenging for both women with systemic lupus erythematosus (SLE) and their treating physicians as it is associated with an inc...
